Allied Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
PCA
MSV
CNB
BTCPP
VFA
GIA
CAM
EB
Allied Investment Advisors's LLY Position: Q3 2026 in Review
Allied Investment Advisors increased its Eli Lilly (LLY) stake by 0.32% in Q3 2026, buying an estimated $1.18K and bringing the position to 312 shares worth $360K. The position accounts for 0.03% of the portfolio, ranked #87.
Allied Investment Advisors first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. The position peaked at $374K in Q2 2026. 428 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Allied Investment Advisors held 312 shares of Eli Lilly worth $360K as of Q3 2026.
- Allied Investment Advisors bought 1 Eli Lilly share in Q3 2026, an estimated $1.18K.
- Eli Lilly made up 0.03% of Allied Investment Advisors's portfolio in Q3 2026, its #87 holding.
- Allied Investment Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
- Allied Investment Advisors's Eli Lilly position peaked at $374K in Q2 2026.
- 428 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Allied Investment Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.